GeneFiX Saliva RNA Collection Device from Harrietsham, UK-based Isohelix, has been selected for use for covid-19 testing by Precision Genetics, a Greenville, SC-based healthcare technology company and high-capacity molecular testing laboratory.
“We are proud that our GeneFix Saliva RNA Collection Device is being used as a valuable, dependable method at the Precision Genetics testing laboratory, where a wide variety of SARS-CoV-2 assays are being implemented to contribute to the global fight against covdi-19,” says Tom Hole, CEO of Isohelix. “Precision Genetics reviewed various saliva collection kits and chose the GeneFix Saliva RNA Collection Device for its superior simplicity and reliable performance.”
The addition of saliva collection to Precision Genetics’ testing capabilities comes at a time when alternative collection methods for covid-19 testing are increasingly important. Saliva collection allows a person to expel their saliva into a tube, making it far less invasive than the nasopharyngeal (NP) collection method. In addition, saliva collection offers ease and convenience for more populations and demographics.
“Saliva collection not only reduces exposure to the SARS-CoV-2 virus for healthcare professionals supervising the collection process, but as importantly offers a less invasive and comfortable alternative for groups that might require this option,” says Nate Wilbourne, CEO of Precision Genetics.
For more information, visit Isohelix and Precision Genetics.
